Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

盘前交易 05-17 04:17:50 EDT

0.4301

-0.0133

-3.00%

最高0.4461	最低0.4300	成交量10.54万
今开0.4400	昨收0.4434	日振幅3.63%
总市值688.52万	流通市值344.95万	总股本1,601万
成交额4.58万	换手率1.31%	流通股本802.02万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":0.4301,"timestamp":1715889600000,"preClose":0.4434,"halted":0,"volume":105435,"delay":0,"floatShares":8020183,"shares":16008469,"eps":-0.327464,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0133,"latestTime":"05-17 04:17:50 EDT","open":0.44,"high":0.4461,"low":0.43,"amount":45804.956823,"amplitude":0.03631,"askPrice":0.5622,"askSize":100,"bidPrice":0.3521,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.327464,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715952600000},"adr":0,"listingDate":1674190800000,"adjPreClose":0.4301,"volumeRatio":1.0154540476510472},"requestUrl":"/m/hq/s/CVKD","defaultTab":"news","newsList":[{"id":"2434289644","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434289644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434289644?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:57","pubTimestamp":1715371020,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日03时57分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅跳水5.23%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110357017a594622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110357017a594622&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431899998","title":"Cadrenal Therapeutics, Inc.盘中异动 临近午盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431899998","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431899998?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:36","pubTimestamp":1714404963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时36分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.81%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292336047a573d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292336047a573d5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429165149","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429165149","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429165149?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:54","pubTimestamp":1713898471,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时54分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速上涨5.57%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.71%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042402543187e82e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042402543187e82e60&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429927419","title":"Cadrenal Therapeutics, Inc.盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429927419","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429927419?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:22","pubTimestamp":1713795744,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时22分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222222487e82854&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222222487e82854&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428965470","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428965470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428965470?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:37","pubTimestamp":1713533827,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时37分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌6.91%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192137077a541c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192137077a541c20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428349106","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428349106","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428349106?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:49","pubTimestamp":1713361771,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时49分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨5.67%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721493187e81613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721493187e81613&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428280811","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.93%报0.381美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428280811","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428280811?lang=zh_cn&edition=full","pubTime":"2024-04-17 01:17","pubTimestamp":1713287831,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日01时17分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌5.93%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170117117a533230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170117117a533230&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426093780","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426093780","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426093780?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928664,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下跌5.30%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213104876f4537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213104876f4537&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426695268","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘急速下挫9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426695268","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426695268?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:32","pubTimestamp":1712842329,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时32分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅下挫9.29%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132108767fa8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132108767fa8d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494269","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌9.49%报0.370美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494269","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494269?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:34","pubTimestamp":1712756053,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时34分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水9.49%。截至发稿，该股报0.370美元/股，成交量22.1839万股，换手率1.39%，振幅6.66%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213413876169b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213413876169b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424821400","title":"Cadrenal Therapeutics, Inc.盘中异动 快速跳水6.14%报0.581美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424821400","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424821400?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:38","pubTimestamp":1712162309,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时38分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速下跌6.14%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404003829791ec2c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404003829791ec2c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422699084","title":"Cadrenal Therapeutics, Inc.盘中异动 急速下跌5.49%报0.613美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422699084","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422699084?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:31","pubTimestamp":1711546270,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时31分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.49%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272131108b69d9d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272131108b69d9d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421460470","title":"Cadrenal Therapeutics, Inc.盘中异动 快速拉升5.00%报0.630美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421460470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421460470?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:36","pubTimestamp":1711028162,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时36分，Cadrenal Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报0.630美元/股，成交量4909股，换手率0.03%，振幅4.95%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212136028b51211a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212136028b51211a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421771284","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘快速上涨5.09%报0.599美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421771284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421771284?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:13","pubTimestamp":1710958423,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时13分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨5.09%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210213447a4dfebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210213447a4dfebc&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":-0.1139},{"period":"1month","weight":0.1031},{"period":"3month","weight":-0.4624},{"period":"6month","weight":-0.0774},{"period":"1year","weight":-0.6971},{"period":"ytd","weight":-0.4187}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。他们专注于开发Tecarfarin，这是一种具有孤儿药适应症的新型疗法，旨在预防终末期肾病患者的心源性全身性血栓栓塞（血凝块）和心房颤动（心律不齐）或 AFib。Tecarfarin 是一种抗凝剂，其药物设计过程针对与血栓形成和 AFib 治疗中最常用的处方药不同的途径。他们于2022年4月1日通过 Horizon Technology Finance Corporation的全资子公司HESP LLC的资产购买协议获得了tecarfarin的权利。","exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}